Monoclonal Antibodies That Target Pathological Assemblies Of Amyloid B (Abeta)

摘要

Disclosed herein are antibodies that bind with high specificity to soluble oligomers of amyloid beta (Abeta) and methods of employing those antibodies. The antibodies are able to distinguish between Alzheimer's Disease (AD) and control human brain extracts. The antibodies identify endogenous Abeta oligomers in AD brain slices and also bind to Abeta oligomers on cultured hippocampal cells. The antibodies neutralize endogenous Abeta oligomers and Abeta oligomers produced in solution.